COVID-19 outbreak has shaken the world and the entire life sciences industry has been committed to bring solutions forward in the fight against the pandemic. How have private and public players been joining forces to facilitate research and development? How have pharma, biotech start-ups, medtech companies, academia and public health agencies concretely been working together on diagnostic, treatments, clinical repurposing, and preventive vaccines? What can be taken away from the experimental partnerships and collaborations that have emerged in this global health crisis context?

Speakers
Rafaela Kunz - bbw Hochschule
Pierre Meulien - Innovative Medicines Initiative
Vassilis Georgiadis - UCL Innovation and Enterprise
Rob Smeets - Philips

Continue your tour